Novartis: all 3,900 studies
Page 29 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- A Global Imatinib and Nilotinib Pregnancy Exposure RegistryCompletedNCT01289054
- BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast CancerWithdrawnNCT01288092Phase 2
- Efficacy of DNK333 in Patients With COPD and CoughCompletedNCT01287325Phase 1/2
- The Gilenya Pregnancy RegistryCompletedNCT01285479
- A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without TrastuzumabCompletedNCT01285466Phase 1
- Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid TumorsCompletedNCT01285453Phase 1
- Observational Registry Study of Renal Transplant PatientsWithdrawnNCT01284257
- A Study of BKM120 in Adult Japanese Patients With Advanced Solid TumorsCompletedNCT01283503Phase 1
- Long Term Study of Fingolimod in MS Patients From the FTY Clinical ProgramCompletedNCT01281657
- Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)CompletedNCT01279473Phase 1/2
- An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic FunctionTerminatedNCT01278849Phase 1
- A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal FunctionTerminatedNCT01278758Phase 1
- Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular LymphomaCompletedNCT01275209Phase 1
- To Determine the Relationship Between Baseline Reversibility and the Efficacy of IndacaterolCompletedNCT01272362Phase 4
- Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With TrastuzumabCompletedNCT01271920Phase 1/2
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- Safety of CHIR-258 (TKI258) in Advanced Solid TumorsTerminatedNCT01270906Phase 1
- Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant RecipientsWithdrawnNCT01269684Phase 4
- Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01266135Phase 2
- Cardiac Safety of IndacaterolCompletedNCT01263808Phase 1
- Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETsCompletedNCT01263353Phase 1
- Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.CompletedNCT01262586Phase 3
- Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial TreatmentCompletedNCT01257815Phase 4
- Safety and Efficacy of Galvus in Elderly Type 2 Diabetes PatientsCompletedNCT01257451Phase 3
- Efficacy of Diclofenac Potassium vs Nimesulide in the Treatment of Fever and Pain in Children With Upper Respiratory Tract InfectionWithdrawnNCT01257126Phase 4
- Intravitreal LFG316 in Patients With Advanced Age-related Macular DegenerationCompletedNCT01255462Phase 1
- Safety and Efficacy of AFQ056 in Adult Patients With Fragile X SyndromeCompletedNCT01253629Phase 2
- Efficacy, Safety, and Pharmacokinetics of QAW039CompletedNCT01253603Phase 2
- This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.CompletedNCT01250951Phase 4
- Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer PatientsCompletedNCT01249456
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)CompletedNCT01242774Phase 1
- A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by MonotherapyCompletedNCT01241487Phase 4
- A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsCompletedNCT01240655Phase 1
- An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404TerminatedNCT01240642Phase 1
- Phase 4 Study in the Elderly Patients With T2DMCompletedNCT01238978Phase 4
- Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential HypertensionCompletedNCT01237873Phase 3
- A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.CompletedNCT01237236Phase 1
- Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus GlimepirideCompletedNCT01233622Phase 3
- Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile InfectionsCompletedNCT01232595Phase 2
- A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive TumorsCompletedNCT01231594Phase 1
- Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With MalariaCompletedNCT01228344
- Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy InfantsCompletedNCT01226953Phase 3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal WomenCompletedNCT01224717Phase 1
- Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT01224366Phase 3
- To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of NilotinibCompletedNCT01223898Phase 1
- Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)CompletedNCT01220648Phase 1
- A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) PatientsCompletedNCT01220115
- A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA GeneCompletedNCT01219699Phase 1
- A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix CancerCompletedNCT01217177Phase 1
- An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular EndpointsCompletedNCT01216085Phase 2
- Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) PatientsCompletedNCT01213641
- Immunogenicity and Safety of V70P5 Revaccination SubjectsCompletedNCT01210898Phase 3
- Immunogenicity and Safety of Different rMenB Plus MenACWY Formulations in AdolescentsCompletedNCT01210885Phase 2
- An East Asian Study of LDE225CompletedNCT01208831Phase 1
- Tasigna in Glivec-resistant or Intolerant Patients in CMLCompletedNCT01206088Phase 4
- Safety, Tolerability and Pharmacokinetics of QAK423A in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01197287Phase 1
- Efficacy and Safety of Combination Therapy of Vildagliptin/Metformin in Patients in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01196546Phase 4
- A Study of BEZ235 in Adult Japanese Patients With Advanced Solid TumorsCompletedNCT01195376Phase 1
- Glycemic Holter Study (Continuous Glucose Monitoring) -CompletedNCT01193296Phase 4
- Certoparin in Renal Patients Undergoing HemodialysisCompletedNCT01179620Phase 3
- Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced DyskinesiasCompletedNCT01173731Phase 2
- Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)CompletedNCT01172548Phase 2
- Clinical Trial With Mesalamine 1g SuppositoriesTerminatedNCT01172444Phase 3
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)TerminatedNCT01170650Phase 3
- Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset SeizuresWithdrawnNCT01167335Phase 2
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Effect of AQW051 on Cognitive Function in Patients With Chronic Stable SchizophreniaCompletedNCT01163227Phase 2
- Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly SubjectsCompletedNCT01161264Phase 3
- Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)CompletedNCT01160094
- Long-term Safety Study of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT01159249Phase 3
- Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)TerminatedNCT01156415Phase 3
- Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid TumorsCompletedNCT01155713Phase 1
- Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)CompletedNCT01155700Phase 3
- A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor PatientsCompletedNCT01155453Phase 1
- Safety of RAD001 in Chinese Patients With Metastatic Renal Cell CancerCompletedNCT01152801Phase 1
- Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly SubjectsCompletedNCT01151059Phase 2
- Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)CompletedNCT01148797Phase 2
- Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011CompletedNCT01147081Phase 3
- Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset SeizuresCompletedNCT01147003Phase 2
- Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe HypertriglyceridemiaCompletedNCT01146522Phase 1/2
- Dose Escalation Study of AUY922 in Advanced Solid Malignancies in JapanCompletedNCT01132625Phase 1
- Efficacy of QAX576 in AsthmaCompletedNCT01130064Phase 2
- Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant PatientsCompletedNCT01128335Phase 2
- Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) PatientsCompletedNCT01127750Phase 3
- A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseCompletedNCT01126892Phase 3
- Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy ChildrenCompletedNCT01125527Phase 3
- Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese VolunteersCompletedNCT01123954Phase 2
- MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5CompletedNCT01121237
- Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus AmlodipineCompletedNCT01113047Phase 3
- Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01110902Phase 3
- Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive DisorderCompletedNCT01110889Phase 3
- Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)CompletedNCT01110668Phase 2
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid TumorsCompletedNCT01106508Phase 1
- An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBECompletedNCT01106482Phase 4
- The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in CanadaCompletedNCT01105507Phase 3
- A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and CetirizineCompletedNCT01103050Phase 2
- Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With AsthmaTerminatedNCT01103037Phase 2
- Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisWithdrawnNCT01103024Phase 3
- Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived VaccineCompletedNCT01101074
- Safety and Efficacy of LCL161 in Patients With Solid TumorsCompletedNCT01098838Phase 1